Sumitomo Mitsui Ds Asset Management Company, LTD Biomarin Pharmaceutical Inc Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $10.9 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 20,387 shares of BMRN stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,387
Previous 20,643
1.24%
Holding current value
$1.13 Million
Previous $1.46 Million
23.24%
% of portfolio
0.01%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding BMRN
# of Institutions
674Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$874 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$837 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$681 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...